Philip W. Kantoff, MD, Named Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center


Get Permission

Philip W. Kantoff, MD

Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS) since 1987 in a variety of capacities.

In his new role, Dr. Kantoff will continue to see patients in addition to heading a program of laboratory-based research. MSK’s experts in medical oncology and nearly all internal medicine subspecialties will report to Dr. Kantoff.

Previous Appointments

Dr. Kantoff was previously Director of the Lank Center for Genitourinary Oncology, Chief of the Division of Solid Tumor Oncology, Vice Chair of the Department of Medical Oncology, and Chair of the Executive Committee on Clinical Research at Dana-Farber, as well as Professor of Medicine at HMS. He was the Jerome and Nancy ­Kohlberg Endowed Chair at HMS, Leader of the Dana-Farber/Harvard Cancer Center Prostate Cancer Program, and Director of its Prostate Cancer Specialized Program of Research Excellence (SPORE).

In his role as Director of the Lank Center, Dr. Kantoff oversaw robust programs of clinical care and research as well as laboratory research. His laboratory focused on the genetics and genetic epidemiology of prostate cancer, mechanisms of resistance to therapies, and the role of noncoding RNAs in prostate cancer, as well as the discovery of biomarkers that may be useful prognostic tools and/or therapeutic targets. He served as a clinical researcher and principal investigator in significant trials devoted to the development of new therapeutic targets for men with advanced prostate cancer.

As Professor of Medicine at HMS since 2004, Dr. Kantoff’s comprehensive research program focused on the molecular basis of genitourinary cancers and improved treatment for patients with prostate, kidney, bladder, and testicular cancers.

Dr. Kantoff currently serves as the Chairman of the Global Treatment Science Network of the Prostate Cancer Foundation. He is a member of numerous professional societies and editorial boards and is board certified in internal medicine and medical ­oncology. ■

 


Advertisement

Advertisement



Advertisement